Results 21 to 30 of about 36,390 (302)

Eosinophilic inflammation: An Appealing Target for Pharmacologic Treatments in Severe Asthma

open access: yesBiomedicines, 2022
Severe asthma is characterized by different endotypes driven by complex pathologic mechanisms. In most patients with both allergic and non-allergic asthma, predominant eosinophilic airway inflammation is present.
Alessandro Vatrella   +5 more
doaj   +1 more source

Experience with mepolizumab in adults with severe eosinophilic asthma: a case series from India

open access: yesRespirology Case Reports, 2021
Severe asthma can be associated with eosinophilic or allergic phenotypes or both. Eosinophilic inflammation is associated with exacerbations and disease severity due to biological activity of interleukin‐5 (IL‐5).
Venkata Nagarjuna Maturu   +7 more
doaj   +1 more source

A Case of Eosinophilic Gastroenteritis Remission Achieved Steroid-Free With Mepolizumab

open access: yesGastro Hep Advances, 2022
Eosinophilic gastroenteritis is an eosinophilic inflammatory disease that responds well to steroids but often relapses upon their discontinuation, necessitating maintenance treatment.
Yuki Hirata   +2 more
doaj   +1 more source

Targeting Eosinophils in Asthma [PDF]

open access: yesCurrent Molecular Medicine, 2008
Recruitment of eosinophils has long been recognized as a hallmark of the inflammatory response in asthma. However, the functions of this population of cells in host defense remain poorly understood. Eosinophils play an important part in the inflammatory response and have key regulatory roles in the afferent arm of the immune response.
Foster, Paul S.   +3 more
openaire   +2 more sources

Severe eosinophilic asthma and aspirin-exacerbated respiratory disease associated to eosinophilic gastroenteritis treated with mepolizumab: a case report [PDF]

open access: yes, 2020
Background: Mepolizumab (MEP) is the first anti Interleukin (IL)-5 add-on therapy approved for the treatment of severe refractory eosinophilic asthma.
C. Di Mario   +11 more
core   +3 more sources

Clinical characteristics of eosinophilic COPD versus COPD patients with a history of asthma

open access: yesRespiratory Research, 2017
Eosinophilic COPD appears to be a distinct patient subgroup with an increased corticosteroid response. Eosinophilic COPD has been labelled as part of the asthma COPD overlap syndrome (ACOS).
Umme Kolsum   +5 more
doaj   +1 more source

Fasting impairs type 2 helper T cell infiltration in the lung of an eosinophilic asthma mouse model

open access: yesFEBS Open Bio, 2021
Eosinophilic asthma is a form of bronchial asthma that is caused by the pulmonary infiltration of eosinophils and accounts for approximately half of the patients with severe asthma.
Yusuke Suzuki   +7 more
doaj   +1 more source

Eosinophilic Inflammation in Allergic Asthma [PDF]

open access: yesFrontiers in Pharmacology, 2013
Eosinophils are circulating granulocytes involved in pathogenesis of asthma. A cascade of processes directed by Th2 cytokine producing T-cells influence the recruitment of eosinophils into the lungs. Furthermore, multiple elements including interleukin (IL)-5, IL-13, chemoattractants such as eotaxin, Clara cells, and CC chemokine receptor (CCR)3 are ...
Possa, Samantha S.   +4 more
openaire   +3 more sources

A community study of factors related to poorly controlled asthma among Brazilian urban children. [PDF]

open access: yes, 2012
BACKGROUND: Asthma constitutes a serious public health problem in many regions of the world, including the city of Salvador, State of Bahia-Brazil. The purpose of this study was to analyse the factors associated with poor asthma control.
Cruz, Alvaro A.   +30 more
core   +1 more source

Home - About - Disclaimer - Privacy